Nature, Published online: 13 February 2023; doi:10.1038/d41586-023-00393-7
An antibody treatment reduces measurements of brain abnormalities called amyloid plaques in people with Alzheimer’s disease, and lessens clinical decline. This result will help in developing therapies to treat and prevent the disease.
More News
Could bird flu in cows lead to a human outbreak? Slow response worries scientists
US halts funding to controversial virus-hunting group: what researchers think
How high-fat diets feed breast cancer